Farms.com Home   News

Shic Provides Context on Chinese ASF Outbreaks and Vaccines

Illegal African swine fever (ASF) vaccine use in China continues, creating concern in the US swine industry. Per a January 21, 2021, report by Reuters, “A new form of African swine fever identified in Chinese pig farms is most likely caused by illicit vaccines, industry insiders say… Two new strains of African swine fever have infected more than 1,000 sows on several farms owned by New Hope Liuhe, China’s fourth-largest producer, as well as pigs being fattened for the firm by contract farmers, said Yan Zhichun, the company’s chief science officer.” USDA Animal and Plant Health Inspection Service (APHIS) says there is information about at least two ASF vaccines being used in China, a situation they continue to monitor and acknowledge may change. One of these vaccines circulating in China at this stage has a deletion of only the CD2 gene and the other with deletions of the CD2 and the MGF genes. Based on this information, APHIS fully expects available ASF PCR tests deployed in the US to be able to detect both vaccine strains.
 
The Swine Health Information Center remains vigilant in its monitoring of the situation. While a proven reliable, tested, and approved vaccine for ASF would be welcome, risks associated with any vaccine versions not shown to be safe and effective are great. Anecdotal information from China, prior to the Reuters report, indicated an unapproved two-gene deleted ASF vaccine version in the Asian nation reportedly causes infection and pathology as well as some death, but the majority of pigs live following vaccination, even though there might be chronic lesions and shedding. Consequently, the ability to detect even these types of vaccine strains via PCR is crucial for safeguarding the US swine herd from risk of exposure due to feed, fomites, products, or by purposeful or accidental introductions.
Click here to see more...

Trending Video

Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Video: Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Genetic research and new technologies continue to influence the future of swine health and production efficiency. In this episode, we explore how research and technology are being used to support stronger, more resilient pigs, while also improving overall production outcomes. In this episode, we are joined by Dr. Jenelle Dunkelberger, geneticist with Topigs Norsvin, to discuss both routine and emerging strategies for improving piglet, pig, and sow livability. She outlines two primary approaches to enhancing resiliency: gene editing and traditional selective breeding. Continuing the resiliency conversation, we also hear from Dr. Lucina Galina, director of technical research projects at the Pig Improvement Company. She shares insights into ongoing gene-editing work focused on PRRS, detailing the pathway to success, regulatory and practical considerations, and the questions that still remain as the technology evolves. Together, these conversations provide a closer look at how research, genetics and innovation are shaping the future of swine health and livability.